Vitamin D Supplementation and Non-Skeletal Disorders: A Comprehensive Review

Introduction to Vitamin D

A recent thorough review has investigated the potential of vitamin D supplements in preventing non-skeletal disorders, such as cardiovascular diseases and mood disorders. The two principal forms of vitamin D are D2 (ergocalciferol) and D3 (cholecalciferol), both of which are crucial for the absorption of calcium, magnesium, and phosphate in the intestines. The majority of vitamin D needed by humans is synthesized through chemical reactions initiated in the skin, with further processes occurring in the liver and kidneys. Dietary sources provide only a minor contribution.

Previous Research Findings

Historically, numerous studies have explored the link between low serum concentrations of vitamin D and various non-skeletal conditions. However, no substantial associations have been confirmed, prompting a team of researchers to conduct a comprehensive review of the latest data.

Study Overview

Research Publication

The findings of this study were published in the journal The Lancet Diabetes & Endocrinology. French scientists collected the most current and reliable studies, performing comparative analyses and summarizing results based on different categories of non-skeletal disorders.

Categories of Vitamin D Doses

The researchers categorized vitamin D doses into four groups: low (less than 10 μg/day), moderate (10–20 μg/day), high (21–49 μg/day), and very high (more than 50 μg/day).

Effects on Health Outcomes

All-Cause Mortality

The analysis of vitamin D’s impact on all-cause mortality revealed that moderate doses of vitamin D3 were associated with a modest yet significant reduction in mortality rates among middle-aged and older adults. However, supplementation with vitamins D, D2, and D3, whether with or without calcium, did not demonstrate protective effects against myocardial infarction, stroke, congestive heart failure, or hypertension. Notably, vitamin D supplementation was related to increased systolic pressure and elevated LDL cholesterol levels in overweight and obese individuals.

Cancer and Metabolic Disease

The review of cancerous and precancerous conditions indicated that vitamin D supplementation did not significantly affect cancer incidence and had minimal impact on reducing cancer mortality. In terms of metabolic conditions, the research revealed that vitamin D supplementation did not influence blood sugar levels or serum concentrations of leptin, a hormone linked to hunger and satiety.

Upper Respiratory Tract Infections and Asthma

The findings showed that vitamin D supplementation reduced the risk of common upper respiratory tract infections by 12% among individuals with low serum levels. However, it did not enhance the condition of patients suffering from pneumonia, tuberculosis, or chronic obstructive pulmonary disease (COPD). On the positive side, vitamin D supplements were effective in lowering the risk of asthma exacerbations necessitating corticosteroid treatment in children, adults, and pregnant women.

Mood Disorders and Other Conditions

Regarding daily functioning, mood, and pain, vitamin D did not improve outcomes for multiple sclerosis, mood disorders such as depression, or chronic pain in various patient populations. Similar results were observed for rheumatic conditions like rheumatoid arthritis and systemic lupus erythematosus, as well as inflammatory conditions like Crohn’s disease. In terms of maternal and perinatal health, researchers found that vitamin D and calcium supplementation could significantly decrease the risk of pre-eclampsia, while vitamin D alone did not yield the same benefits.

Conclusion

Despite previous studies suggesting that vitamin D supplementation has minimal impact on non-skeletal disorders, this comprehensive analysis indicates that such supplementation may reduce all-cause and cancer mortality among middle-aged and older adults, as well as the risk of upper respiratory infections and asthma exacerbations. However, evidence supporting a critical role for vitamin D in most non-skeletal disorders remains limited. The authors propose that low vitamin D status is more likely a consequence of poor health rather than its cause, advocating for larger trials to further investigate these associations. Current ongoing trials primarily involve high-resource countries, highlighting the necessity for studies in diverse socioeconomic and health service environments.

References

(1) Autier P, Mullie P, Macacu A, Dragomir M, Boniol Magali, Coppens K, Pizot C, Boniol Mathieu. Effect of vitamin D supplementation on non-skeletal disorders: a systematic review of meta-analyses and randomised trials. Lancet Diabetes Endocrinol 2017; 5: 986-1002.
(2) Vitamin D – Fact Sheet for Health Professionals. Retrieved from https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/
(3) Gunnars, K. (June 4, 2017). Leptin and Leptin Resistance: Everything You Should Know. Retrieved from https://www.healthline.com/nutrition/leptin-101